CA1060904A - Preparation of indanylpropionic acids - Google Patents

Preparation of indanylpropionic acids

Info

Publication number
CA1060904A
CA1060904A CA308,574A CA308574A CA1060904A CA 1060904 A CA1060904 A CA 1060904A CA 308574 A CA308574 A CA 308574A CA 1060904 A CA1060904 A CA 1060904A
Authority
CA
Canada
Prior art keywords
group
reaction
formula
acid
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA308,574A
Other languages
French (fr)
Inventor
Norio Yoshida
Kiichiro Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50020696A external-priority patent/JPS5740132B2/ja
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to CA308,574A priority Critical patent/CA1060904A/en
Application granted granted Critical
Publication of CA1060904A publication Critical patent/CA1060904A/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ABSTRACT OF THE DISCLOSURE
The preparation of compounds of the formula (VI) wherein R represents an ethyl group or an isopropyl group, or a pharmaceutically accep-table salt thereof, which comprises reacting a compound having the formula (I) wherein R represents an ethyl group or an isopropyl group with a reducing agent capable of reducing the carbonyl group to a methyle?
group without reducing the carboxyl group and when required salify?
the reaction product to obtain a pharmaceutically acceptable salt thereof.

Description

This invention relates to the synthesis of compouncls having valuabl.e pharmaceutical properties.
This application is a divisional application of copendi application No. 246,057 filecl Feb. 18r 1976.
The copending application provides oxoindanylpropionic acids having the formula o R ~ C~I-COOII (I) wherein R represents an ethyl group or an isopropyl group.
: ~s described in our Canadian Patent Application I~o.
219,910wehave previously discovered substituted idanylpropionic acids of formula R ~ CI~-COOH ~VI) (wherein R has the meaning previously given) and pharmaceutically ~- acceptable salts thereof which exhibit anti-inflammatory, analgesic and antipyretic activities; and we have also described therein the `.~

~` 30 ,' ~ ~

;

- 1061)904 ~reparatiOn of these compound by hydrolysis of the corresponding acid amide, nitrile or alkyl esters. ~e have now further discovered that these substituted indanylpropionic acids of formula (VI) can advantageously be prepared by the reduction of the oxoindanylpro-pionic acids offormula (I) of the copending application 246,037.
According to the present invention therefore there is provided a process for preparing a compound of formula H-COOH

R ~ CH3 (VI) . .
wherein R represents an ethyl group or an isopropyl group or a pharmaceutically accep- :
table salt thereof, which comprises reacting a compound having the ` formula O

~ ~ fH-COOH
~ CH3 (I) wherein R represents an ethly group or an isopropyl group with a reducing agent capable of reducing the carbonyl group to a methylene group without reducing the carboxyl group, and when ~: required salifying the reaction product to obtain a pharmaceutically ~: acceptable salt thereof.
The oxoindanylpropionic acids of formula (I) can be prepared by reacting a dicarboxylic acid of formula ~ CH-COOH

.- HOOC-CH-CH2 ~ CH3 (II) R
- 2 -:' f ~j 10~90~
(wherein R has the meaning previously given) with a condensing agent. A conventional condensing agent can be used in the reaction, for example a mineral acid such as polyphosphoric, sulphuric or hydrofluoric acid, a mixture of phosphorus pentoxide and methane-sulphonic acid, or a Lewis acid such as aluminium chloride or boron trifluoride etherate. The reaction is usually performed with heating to a temperature of from 50C to 120C. The reaction period varies with the reaction ternperature, but is generally from 1 to 5 hours. In most cases, the condensing agent can also serve as reaction solvent and a separate solvent is not necessary, but when the .. ' ~ .

'~

:`
. 20 . ~ .

'' ;

, - .
.

condensing agent is a Lewis acid it is preferred to employ a solvent of the type normally used in Friedel-Crafts reactions, for example carbon disulphide or ligroin.
After completion of the reaction, the desired product of formula (I) can be recovered from the reaction mixture by con-ventional means: for example, the reaction mixture is poured into ice-water, the resulting mixture is extracted with a suitable organic solventS such as ether, the extract is washed with water and dried, and the solvent is distilled off from the extract to give the desired product. If required, the product can be purified by the usual methods, such as vacuum distillation or column chroma-tography; or alternatively, it can be salified with an organic amine, for instance piperidine, morpholine, triethylamine, dicyclo-hexylamine or dibenzylamine, and purified by recrystallization of ` the salt.
The starting materials of formula (II) are also new ; compounds and can be prepared by the process shown in the following ; reaction scheme: -.:

.; ' .~.
"~.
,, .
.~ ' ' .

, - 3 -' 10609(~'~

~ ICOOR2 1 ~CH-COOR

XCHzl~ C~3~C00~2 1 3 (III)(IV) (V) , ~CH-COOH
-HOOC-CH-CH2--~ ~ 3 ( II) . . , .:
wherein R has the meaning previously given, each of R and R
represents an alkyl group having from 1 to 4 carbon atoms, and X represents a chlorine or bromine atom.

The substituted benzyl halide (III), which is the starting material in the process shown in the reaction scheme, can be prepared by the method described by J. M. Maillard et al., in Chimie Therapeutique, vol. 8, 487 (1973). This is then reacted ;~ 10 with the malonic ester (IV) in the presence of an alkali metal base, ~ in an inert organic solvent, to obtain the tricarboxylic acid ester (V).
; Suitable examples of the alkali metal base for use in this reaction are alkoxides such as sodium methoxide, sodium ethoxide , and potassium t-b;lltoxide, amides such as sodium amide and potassium ',' 15 amide, and hydrides such as sodium hydride and potassium hydride.
The reaction solvent is preferably an alcohol such as methanol, (4) ;:

,, .
. , ~ : ~ ' ':
.:

1060so~a ethanol or t-butanol, a diaL'cylamide of an alkanoic acid such as dimethylformamide or dimethylacetamide, dimethylsulphoxide, an ether such as tetrahydrofuran, dioxane or 1, 2-dimethoxyethane, or an aromatic hydrocarbon such as benzene, toluene or xylene.
The reaction is preferably performed at a temperature of 0-50 C
and for a period of 1-5 hours. The product (V) can be isolated from the reaction mixture by conventional means: for example, the mixture is poured into ice-water and acidified e. g. with hydrochloric acid, the resulting mixture is extracted with a suitable .
organic solvent, and the extract is washed with water, dried and evaporated to dryness, The tricarboxylic acid ester (V) is hydrolyzed and then decarboxylated to give the dicarboxylic acid (II). The hydrolysis can be effected by treating compound (V) with an aqueous acid ; ~ (e. g. hydrochloric, hydrobromic or sulphuric acid) or base (e. g. sodium hydroxide or potassium hydroxide). The reaction is preferably performed in water or in an aqueous organic solvent, ` for instance aqueous methanol, ethanol, n. propanol, ethylene 5: glycol, diethylene glycol, dimethylformamide or dimethylacetamide.
The reaction temperature is usually from room temperature to 110 C
and the reaction time from 1 to 12 hours, The product can be recovered by conventional means. The product can be decarboxylated by heating it to 100-200 C, optionally in the presence of a solvent, `

(S) .

~ ' ' 106()904 for instance a dialkylamide of an alkanoic acid such as dimethyl-formamide or dimethylacetamide, or an aromatic hydrocarbon such as toluene, xylene or cymene. If a solvent is not employed, the decarboxylation is preferably performed under reduced pressure or under an atmosphere of a gas inert to the reaction, such as nitrogen, in order to suppress side-reactions. The reaction period varies with the temperature and the nature of the starting material, but is generally from 15 minutes to 3 hours, The product of formula (II) can be isolated from the reaction mixture by conventional means, for example by distilling off the solvent, if one is used, and purifying the residue by recrystallization or column chromatography.

; The reduction of the oxoindanylpropionic acids (I) to ~ '~
the pharmaceutically active indanylpropionic acids (VI) can be effected by means of reducing agents conventionally used for converting a keto group to a methylene group without reducing a carboxyl group which is also present in the molecule, For example, the reduction can be performed by means of zinc amalgam and hydrochloric acid (Clemmensen reduction), by catalytic hydro-genation in the presence of a metal catalyst such as palladium on , ~ carbon, palladium oxide, platinum oxide or platinum black, by , means of hydrazine and a base such as sodium hydroxide or sodium ethoxide (Wolff-Kishner reduction), or by means of an alkyl '' ,~ t6) ~
'' ,:- .

mercaptan such as 1, 2-ethanedithiol and a desulphurization catalyst such as Raney nickel (Dithioacetal reduction). It is preierred to use zinc amalgam and hydrochloric acid or catalytic hydrogenation.
When performing the reduction by hydrogenation in the presence of a catalyst such as palladium on carbon, it is preferred to add an acid, such as sulphuric, perchloric, trifluoroacetic or p-toluene-sulphonic acid, in the conventional manner. The choice of reaction solvent is not particularly critical, provided that it does not participate in the reaction, but it is preferred to use water, an organic solvent such as an alcohol (e. g. methanol, ethanol or n-propanol), an ether ~e. g. tetrahydrofuran, dioxane OD~ 1, 2-dimethoxyethane), a glycol (e. g. ethylene glycol, diethy~ene glyeol j ~ or triethylene glycol) or an acid such as acetic or prop~onie acid, or a mixture of such an organic solvent with water. The reaetion temperature is also not partieularly critical and may g~nerally be from room temperature to about 200 C - thus, catalyti~ hydrogenation may conveniently be performed at room temperature ar~d at atmos-' pheric pressure, or under a pressure 2-3 times atmospheric, while the other types of reduction are preferably effected with heating to 70-~00 C. The reaction time varies with the temperature and the type of reducing agent employed, but is generally from l to 24 hours.

After completion of the reduction, the desired produet of formula (VI) can be recovered from the reaction mixture by , ~: ' ~ .
~,'', ~ ' .

` :106090~

conventional techniques: for instance, the reaction mixture is filtered to remove insolubles, the filtrate is extracted with a suitable organic solvent, the organic extract is washed with water and dried, and the solvent is distilled off from the extract to give the desired product. If required, the product thus obtained can be purified by conventional means such as recrystallization, vacuum distillation or column chromatography.

- The indanylpropionic acids of formula (VI) thus obtained can be saiified in the conventional manner, to yield pharmaceutically acceptable salts such as those with aL~ali or alkaline earth metals (e, g. the sodium, potassium, calcium and aluminium salts), the ammonium salt, and salts with organic bases (e. g. the triethylamine, dicyclohexylamine, dibenzylamine, piperidine and N-ethylpiperidine ; salts).

Due to the presence of asymmetric carbon atoms, the compounds of formulae (I) and (VI) exhibit optical isomerism; When mixtures of optical isomers are obtained, these can be resolved by the conventional techniques, to isolate the individual optical isomers.
As used in this Specification, the formulae (I) and (VI) are intended to include the individual optical isomers, as well as mixtures thereof.
,, The pharmacological properties of the compounds of .

' (8) "' ~.

,.. . ~ .,.

formula (VI) and suitable formulations for their administration are described in our CQ.~2adian Patent Application No. 219910.

The process of the present invention for preparing the pharmaceutically active compounds of formula (VI) is commercially more advantageous than the earlier process referred to hereinabove, : ~ . since in the earlier process the yields of intermediates are relatively lower and their isolation is relatively difficult by comparison with the present process.

~ !

~'' ' ;'''' . . .
. .'~ `
.

`
''~', , .
.. ,. ~

' .
, i~,. .

.
~ ;', , ' ' (9) ~,"''' .
~,, !

/.'.' :
.' 106090~

The invention is illustrated by the following Examples.

E ~ample 1 2-(2-Isopropylindan-5-yl)propionic acid (VI) (1) Ethyl 2 -l4 -(2, 2 -diethoxycarbonyl-3 -methyl-butyl)-phenyl]propionate (V) 70 g of diethyl isopropylmalonate were added dropwise to a mixture of 8, 5 g of a 50% suspension of sodium hydride in mineral oil and ' 180 ml of dimethylformamide, at a temperature below 30 C; then 40 g of ethyl 2-(4-chloromethylphenyl)propionate were added dropwise to the resulting solution at 20-30C, and the mixture was stirred for 2 hours at 40 C. The reaction mixture was then poured into 50Q ml of ice-water, acidified with hydrochloric acid and extracted with ether. The extract was dried over anhydrous sodium , sulphate and evaporated to dryness. The residue was distilled under reduced pressure, giving 41 g of the desired product as a colourless oil boiling at 159-160 C/0. 005 mmHg, Analysis:

Calculated for C22H32O6 (%): C, 67- 32; H~ 8- 22 :.
- Found (%): C, 67. 82; H, 8. 47 ,......................................................................... .
(2) 2-[4-(2-Carboxy-3-methylbutyl)phenyl]-propionic acid lII) 40. 8 g of ethyl 2-[4-(2, 2-diethoxycarbonyl-3-methylbutyl)phenyl]-:: :
,,, (10) -propionate were added dropwise to a mixture of 80 g of potassium hydroxide and 80 ml of water at 105C, and the mixture was refluxed for 7 hours. After cooling, the ml~ture was washed wit}l ether, acidified with concentrated hydrochloric acid, and extracted with ether. The extract was washed successively with water and aqueous sodium chloride solution, dried over anhydrous sodium sulphate and evaporated to dryness. The residue was heated for 1 hour at 180-200 C under a pressure of 15 mmHg, giving 26 g of the desired product as a pale yellow semi-solid, . . .
(3) 2-(2-Isopropyl-l-oxoindan-6-yl)propionic acid (I) 26 g of 2-[4-(2-carboxy-3-methylbutyl)phenyl]propionic acid were added to 120 ml of concentrated sulphuric acid. The mixture was heated for 3 hours at 100 C, then poured into ice-water and extracted with ether. The extract was washed with water, dried over anhydrous sodium sulphate and evaporated to dryness. Vacuum distillation of the residue gave 15.7 g of the desired product as a colourless oil boiling at 184 C/0. 002 mmHg.
~ .
Analysis:
Calculated for C15H18O3 (%): C, 73- 14; H~ 7- 37 ., ; Found (%): C, 73. 08; H, 7. 51 The corresponding morpholine salt had a melting point of 130-132 C.
'"
", ( 1 1 ) ..

, , "

.
(4) 2-(2-Isopropylindan-5-yl)propionic acid (VI) (a) A mixture of 15 g of 2-(2-isopropyl-1-oxoindan-6-yl)propionic acid, 40 g of zinc amalgam, 50 ml of concentrated hydrochloric acid, 200 ml of dioxane and 30 ml of water was heated under reflux for 15 hours. After completion of the reaction, the reaction mixture was extracted with ether. The ether extract was washed with water and dried over anhydrous sodium sulphate. The solvent was distilled off from the extract and the residue was recrystallized from n-hexane, giving 9. 5 g of the desired product as colourless crystals ., with a melting point of 90-91_'5 C.
Analysis:
:
Calculated for C15H20O2 (%): C, 77- 55; H~ 8- 68 Found (%): C, 77. 62; H, 8. 73 ... .

Aluminium bis~2-(2-isopropylindan-5-yl)propionate]
2. 32 g of 2-(2-isopropylindan-5-yl)propionic acid and 1. 02 g of aluminium isopropoxide were added to 30 ml of toluene. The mixture was heated under reflux for 3 hours, then 10 ml of water and 20 ml of isopropanol were added to it, and the resulting mixture was heated under reflux for another 12 hours, After completion of the reaction, the solvent was distilled off under reduced pressure and 30 ml of ethanol were added to the residue. The precipitate which formed was recovered by filtration, giving 2. 2 g of the desired product as white crystals.

(12) , . .

.
i,' - "'' ~ , 106090~

Analysis:
Calculated for C30H3gosAl~ H2O (%) C, 68.68; H, 7. 87 Found (%): C, 68, 93; H, 7. 50
- 5 (b) A mixture of 1 g of 2-(2-isopropyl-1-oxoindan-6-yl)propionic acid, 0, 2 g of lO~ palladi~m pr. carbon, 0.1 ml of concentrated sulphuric acid and 20 ml of ethanol was subjected to catalytic hydrogenation at room temperature and under atmospheric pressure, After the theoretical amount of hydrogen had been absorbed, insolubles were filtered off and washed with ethanol. The washings were combined with the filtrate and the solvent was distilled off.
The residue was taken up in 20 ml of water and extracted with ether.
The ether extract was washed with water and dried over anhydrous sodium sulphate. The solvent was distilled off from the extract and the residue was recrystallized from n-hexane, giving 0. 7 g of the ...
desired product as colourless crystals with a melting point of ;i 90-91. S C. No depression of melting point was observed in a mixed melting point determination using a sample of these crystals ,; together with a sample of the product of Example 1 (4)~a), and the two products also had completely identical infra-red spectra, . .

Example 2 2-(2-Ethylindan-5-yl)propionic acid (VI) s (13) :

l060so4 (1) 3~thyl 2-14-(2, 2-diethoxycarbonyl-butyl)phenyl~propionate (V) 11. 3 g of diethyl ethylmalonate were added dropwise to a mixture of 3. 0 g of a 50~o suspension of sodium hydride in mineral oil and 50 ml of dimethylformamide, at a temperature below 50 C, then 11. 3 g of ethyl 2-(4-chloromethylphenyl)propionate were added dropwise to the resulting solution at 20-30 C, and the mixture was stirred for 2 hours at 70 C. The reaction mixture was then worked up as in Example 1 (1), giving 14, 4 g of the desired product as a pale yellow oil boiling at 140-146C/0. 02 mmHg.
::
Analysis:
Calculated for C21H30O6 (%): C, 66- 64; H, 7- 99 - Found (%): C, 66. 61; H, 7. 63 (2) 2-[4-(2-Carboxybutyl)phenyl]propionic acid (II) ~ -14 g of ethyl 2-[4-(2, 2-diethoxycarbonylbutyl)phenyl]propionate were added to a mixture of 14 g of potassium hydroxide, 100 ml of water and 10 ml of ethanol, and the resulting mixture was refluxed for
6 hours. The reaction mixture was then worked up as in Example 1 (2), giving 11.1 g of a pale yellow oil. This oil was heated for 3 hours at 160-170 C and subjected to vacuum distillation, giving
7, 2 g of the desired product as a colourless oil boiling at 230 C/
:
- ~ 0. 05 mmHg, : , :

~ ( 14 ) , ' ' '' .

,, :
.

~, - . ., . - -: . ` , - ' ' .~ . . . .

Analysis:
Calculated for C14H18O4 (%): C, 67-18; H~ 7- 25 Found (%) C, 67. 03; H, 7. 37 (3) 2-(2-Ethyl-l-oxoindan-6-yl)propionic acid (I) 7 g of 2-[4-(2-carboxybutyl)phenyl]propionic acid were added to 35 ml of concentrated sulphuric acid and the mixture was heated for 1 hour at 100 C. The reaction mixture was then worked up as in Example 1 (3), giving 4,1 g of the desired product as a colourless oil boiling at 197-200 C/0. 15 mmHg.
Analysis-~! Calculated for C14H16O3 (%~: C, 72- 39; H, 6~ 94 .~, ` Found (%): C, 72. 32; H, 7,10 The corresponding piperidine salt had a melting point of 85-86 C.

(4) 2-(2-Ethylindan-5-yl)propionic acid (VI) lS A mixture of 10. 5 g of 2-(2-ethyl-1-oxoindan-6-yl)propionic acid, .:
20 g of zinc amalgam, 30 ml of concentrated hydrochloric acid, 150 ml of dioxane and 20 ml of water was heated under reflux for 15 hours. After completion of the reaction, the reaction mixture was extracted with ether. The ether extract was washed with water and dried over anhydrous sodium sulphate. The solvent was distilled off from the extract and the residue was subjected to vacuum distillation, giving 8. 2 g of the desired product as a colourless oil (15) ' --106~)904 with a boiling point of 165-166 C/l. 5 mmHg.
Analysis:
Calculated for C14H1802 (%): C, 77. 03; H, 8. 31 Found (%): C, 76, 95; H, 8. 35 2-(2-Ethylindan-5-yl)propionic acid piperidine salt 360 mg of 2-(2-ethylindan-5-yl)propionic acid were dissolved in 2 ml of benzene, and 200 mg of piperidine were added to the solution.
The solvent was distilled off under reduced pressure, and the residue was cooled, giving 300 mg of a white powder. This powder was recrystallized from a mixture of chloroform and petroleum ether, giving the desired product as colourless prisms with a melting point of 95-96C (with decomposition), Analysis:
Calculated for C19H2gO2N (%):
C, 75. 2~; H, 9.63; N, 4.62 :
Found (%): C, 74. 70; H, 9. 89; N, 4. 83 Sodium 2-(2-ethylindan-5-yl)proplonate - A solution of 2. 2 g of sodium- hydroxide in 9 ml of water and 21 ml of ethanol was added to 12, 2 g of 2-(2-ethylindan-5-yl)propionic acid. After dissolution was complete, the solvent was distilled off under reduced pressure and ether was added to the residue. The precipitate which separated out was recovered by filtration and washed (16) '' ' ' ~
' with ether, giving 12. 9 g of a white powder. This powder was recrystallized from a mixture of ethanol and ether, ~iving the desired product as white needles with a melting point of 178-181 C.
Analysis:
Calculated for C14H1702Na (%): C, 69. 98; H, 7.13 Found (%): C, 70. 33; H, 7. 29 ,.

r (17) . ' .

Claims (4)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for preparing a compound of formula (VI) or a pharmaceutically acceptable salt thereof wherein R represents an ethyl group or an isopropyl group which comprises reacting a compound having the formula (I) wherein R represents an ethyl group or an isopropyl group with a reducing agent capable of reducing the carbonyl group to a methylene group without reducing the carboxyl group, and when required sali-fying the reaction product to obtain a pharmaceutically acceptable salt thereof.
2. A process according to Claim 1 wherein said reducing agent is zinc amalgam and hydrochloric acid, hydrogen gas and a metal catalyst, hydrazine and a base, or an alkyl mercaptan and a desulphurization catalyst.
3. A process as claimed in claim 1 in which R is ethyl.
4. A process as claimed in claim 1 in which R is isopropyl.
CA308,574A 1975-02-19 1978-08-02 Preparation of indanylpropionic acids Expired CA1060904A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA308,574A CA1060904A (en) 1975-02-19 1978-08-02 Preparation of indanylpropionic acids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP50020696A JPS5740132B2 (en) 1975-02-19 1975-02-19
CA246037A CA1054630A (en) 1975-02-19 1976-02-18 Substituted indanylpropionic acids
CA308,574A CA1060904A (en) 1975-02-19 1978-08-02 Preparation of indanylpropionic acids

Publications (1)

Publication Number Publication Date
CA1060904A true CA1060904A (en) 1979-08-21

Family

ID=27164339

Family Applications (1)

Application Number Title Priority Date Filing Date
CA308,574A Expired CA1060904A (en) 1975-02-19 1978-08-02 Preparation of indanylpropionic acids

Country Status (1)

Country Link
CA (1) CA1060904A (en)

Similar Documents

Publication Publication Date Title
CA1113113A (en) Cycloalkane-substituted phenylacetic acid derivatives, their use and preparation
CA1116611A (en) Imidazole derivatives exhibiting anticonvulsant activity
US2766285A (en) Substituted aminopropynes and process for their preparation
SU453823A3 (en) METHOD OF OBTAINING 4-
CA1060904A (en) Preparation of indanylpropionic acids
Brace α-Amino alkanoic and alkenoic acids with perfluoroalkyl terminal segments
CA1054630A (en) Substituted indanylpropionic acids
JPS638368A (en) 4-benzyloxy-3-pyrroline-2-one-1-ylacetamide,manufacture and use
JPS5949207B2 (en) Diene manufacturing method
US4393008A (en) 2-Cyano-2-(3-phenoxy-phenyl)-propionic acid amide and preparation thereof
US4568762A (en) 4-Methyl-2-oxo-cyclopentylidene acetic acid and esters thereof
JPH0352881A (en) Preparation of tetronic alkylate
US3910958A (en) Process for preparing arylacetic acids and esters thereof
JPS584699B2 (en) Substituted phenylacetic acid derivatives and their production method
JPS629098B2 (en)
US5840964A (en) Process for the preparation of the enantiomers of 2-(2-fluoro-4-biphenyl)propionic acid
US4201870A (en) Process for the preparation of 2-(3-benzoylphenyl)-propionic acid
EP0220025A1 (en) 3-perfluoroalkyl-5-hydroxyisoxazoles
JPS61137834A (en) Novel phenol ketone derivative and preparation of (6)-gingerol or (6)-shogaol via said derivative
EP0000152A1 (en) Oxaminic acids and esters, process for their preparation and pharmaceutical compositions containing them
US4169858A (en) Process for preparing a ketone
EP0013726B1 (en) Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them
EP0366149A1 (en) Improved process for the synthesis of 3-chloro-2,4,5-trifluorobenzoic acid
JPS62126164A (en) 4-alkoxy-2-oxo-pyrrolidine-1 acetic acid alkyl ester and manufacture
CH638176A5 (en) (N-BENZYL-O- (2,6-DICHLORANILINO) PHENYL) ACETIC ACID DERIVATIVES, THEIR PRODUCTION AND THE USE THEREOF FOR THE PRODUCTION OF (O- (2,6-DICHLORANILINO) PHENYL ACETIC ACID OR THEIR SALTS.